FDA Panel Rejects Novartis Drug for Heart Failure

A Food and Drug Administration advisory committee voted against the approval of a Novartis drug for acute heart failure, but the company said it plans to persist in developing the drug.



from WSJ.com: US Business http://ift.tt/1iFW9kP

via IFTTT